Previous Close
$
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$65.2 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Community
- 0 posts discussing
0
Watchers
0
Visitors